Julie Jordan insider trades

Open-market stock purchases and sales by Julie Jordan, Chief Medical Officer at Neurogene Inc, from SEC Form 4 filings since Aug 2, 2023.

Recent trades

DateStockTradeValue
Mar 26, 2026NGNE Neurogene IncSold$18.1K
Feb 20, 2026NGNE Neurogene IncBought (not open market)—
Feb 20, 2026NGNE Neurogene IncBought (not open market)—

Companies traded

  • NGNE Neurogene Inc: 1 sale, last Mar 26, 2026
  • FIXX Homology Medicines, Inc: 4 sales, last Aug 3, 2023

Get free alerts when Julie Jordan files a new trade →